Washington, DC 20006-5349
HELPLINE
MESOTHELIOMA NEWS
Scroll to find news of interest to you, or search by category. The Mesothelioma Applied Research Foundation covers mesothelioma news for patients and their families. Our write-ups are heavily reliant on peer-reviewed medical research studies with input from mesothelioma experts from around the world but are also accessible to non-medical readers.
Many mesothelioma patients beat their odds and go on to live rich, fulfilling lives. This panel has three long term patients who discuss the issues
Mesothelioma is often thought of as a cancer that only affects older men, but that statistic is changing. Many patients are under the age of
A mesothelioma diagnosis affects more than just the patient. The patient’s family members are also heavily influenced taking on a emotional load as well as
Cannabis is popular among mesoethelioma patients for pain management as a complementary treatment. This session focuses on how cannabis can help mesothelioma patients in pain
Mental health is a big issue for mesothelioma patients, caregivers, and family members. This session covers how patients as well as their loved ones can
CAR-T (Chimeric antigen receptor) cell therapy is a type of immunotherapy that uses a patient’s T cells to attack cancer cells. T cells are white
For patients with MPM (Malignant Pleural Mesothelioma), the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA® (pembrolizumab) as a first-line treatment when combined with
Mesothelioma has often been classified as a cancer that only affects older people, as the average age of diagnosis for pleural is 72 and peritoneal